Fatty diet activates oldest branch of immune system, causing intestinal tumors

September 26, 2016, Perelman School of Medicine at the University of Pennsylvania
cancer
Killer T cells surround a cancer cell. Credit: NIH

A high-fat-diet-induced immune reaction causes inflammation leading to intestinal cancer in a mouse model – even among animals that are not obese—according to a new study from the Perelman School of Medicine at the University of Pennsylvania, Case Western Reserve University, the Pacific Northwest Research Institute (PNRI), and others. Epidemiological and clinical evidence have linked obesity with inflammation and increased risk of cancer. Up to now, however, the molecular mechanisms linking these three conditions have been elusive. The interdisciplinary team published their findings in Molecular Cancer Research.

"We found that specific types of high-fat diets – based on corn or coconut oils like those found in certain salad dressings and ice cream—are associated with increased tumor formation in a mouse model of intestinal cancer," said co-senior author John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine at Penn. "This model is particularly interesting because it resembles human familial adenomatous polyposis, a condition that carries an 80 percent risk of developing colorectal cancer in individuals with mutations in a called Apc."

While increased tumor formation was associated with mice fed corn or coconut fats, mice fed diets with olive oil as a source of fat did not develop intestinal polyps, despite being obese. "This observation led us to our first important conclusion that diet, but not necessarily obesity, can promote intestinal cancer," said co-author Edimara Reis, PhD, a research associate in the Department of Pathology and Laboratory Medicine. In fact in late September, the FDA decided to give the food industry three years to phase out partially hydrogenated oils, the main source of trans fat in some foods based on corn oil and other types of fat.

Using the , which was developed by co-senior author Joseph Nadeau from PNRI and first author Stephanie Doerner from Case Western, the team concluded that a high-fat diet (rather than metabolic status) and the chemical composition of the diet are the most important factors for determining . "Our results clearly show that eating a high-fat diet is sufficient to increase cancer risk, regardless of obesity," said co-senior author Nadeau.The team also noted that was caused by inflammation induced by the corn- and coconut-based diets. Notably, inflammation and intestinal tumors in the mice were triggered very soon – three days—after being fed these high-fat diets.

Specifically, the corn- and coconut-based HFDs, not the olive oil-based diet, activated the complement system, an arm of the innate immune system. Complement is an evolutionarily conserved network of proteins that regulate immune responses that destroy foreign invaders. The system is a rapid defense mechanism in most species, from primitive sponges to humans. Complement also has inflammatory functions, and the Lambris lab has been investigating C5aR (the C5a receptor) for more than two decades. In the current study, C5a, a related pro-inflammatory molecule, increased in the intestine and systemically in mice fed corn- and coconut-based HFDs.

"When mice were given a drug to reduce the activity of C5aR, it prevented the development of intestinal tumorigenesis in mice fed corn- and coconut HFDs, indicating that anti-complement therapy could act as an adjuvant with cancer treatments," Lambris said. The team also surmises that a diet change and complement inhibitors could potentially be beneficial to people with the apc mutation to prevent carcinogenesis.

The team is now working on understanding the exact biochemistry of how certain HFDs activate complement with the production of the C5a molecule. This work was funded by the National Institutes of Health (U54 CA116867, AI030040, AI068730, P40 RR012305).

Explore further: Gut microbes spur development of bowel cancer

More information: S. K. Doerner et al. High-fat diet-induced complement activation mediates intestinal inflammation and neoplasia, independent of obesity, Molecular Cancer Research (2016). dx.doi.org/10.1158/1541-7786.MCR-16-0153

Related Stories

Gut microbes spur development of bowel cancer

March 3, 2014
It is not only genetics that predispose to bowel cancer; microbes living in the gut help drive the development of intestinal tumors, according to new research in mice published in the March issue of The Journal of Experimental ...

Could bacteria help fight colorectal cancer?

December 3, 2015
Obesity is a major risk factor for developing colorectal cancer, the second leading cause of cancer deaths in the United States. But someday doctors may be able to lessen the effect of that risk factor.

Sugar in western diets increases risk for breast cancer tumors and metastasis

January 1, 2016
The high amounts of dietary sugar in the typical Western diet may increase the risk of breast cancer and metastasis to the lungs, according to a study at The University of Texas MD Anderson Cancer Center.

Study explores how high-fat diet influences colon cancer

March 2, 2016
A study published today in Nature reveals how a high-fat diet makes the cells of the intestinal lining more likely to become cancerous. It joins a growing body of research that finds obesity and eating a high-fat, high-calorie ...

Rat fathers' diets may affect offspring's breast cancer risk

July 25, 2016
The dietary habits of rat fathers may affect their daughters' breast cancer risk, a study in 60 male rats and their offspring has found. The study is published in the open access journal Breast Cancer Research. Researchers ...

Retinoic acid suppresses colorectal cancer development, study finds

August 30, 2016
Retinoic acid, a compound derived in the body from vitamin A, plays a critical role in suppressing colorectal cancer in mice and humans, according to researchers at the Stanford University School of Medicine.

Recommended for you

Research team discovers drug compound that stops cancer cells from spreading

June 22, 2018
Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body. New research, published today in the journal Nature ...

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.